According to a report by Revista Forum, a 47-year-old man named Arnaldo Machado was hospitalized and forced to undergo treatment for seven months due to lung issues caused by the use of an e-cigarette. He now warns about the dangers of this device and opposes the ongoing debate in France seeking its legalization.
Machado developed a lung disease called "EVALI" after using an e-cigarette device. This disease was first described in the United States in 2019 and is associated with the use of e-cigarette devices.
His lungs have developed a fatty wall, similar to how fat in the lungs obstructs his breathing. He opposes the legalization of the product and calls on authorities to completely ban it. The aerosol produced by this device, known as e-liquid, may contain various harmful substances such as nicotine, heavy metals, and flavorings, which users may inhale.
Furthermore, the use of e-cigarettes may lead to nicotine dependence, increase the risk of adolescents initiating smoking, and potentially cause damage to the oral mucosa, resulting in throat and eye pain, rhinitis, pneumonia, and other diseases.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
